Amplification of anticancer efficacy by co-delivery of doxorubicin and lonidamine with extracellular vesicles
Chemotherapy is commonly used for the treatment of lung cancer, but strong side effects and low treatment efficacy limit its clinical application. Here, extracellular vesicles (EVs) as natural drug delivery carriers were used to load conventional anticancer drug doxorubicin (DOX) and a chemosensitiz...
Saved in:
Main Authors: | Huizhen Li (Author), Wan Xu (Author), Fang Li (Author), Ru Zeng (Author), Xiuming Zhang (Author), Xianwu Wang (Author), Shaojun Zhao (Author), Jian Weng (Author), Zhu Li (Author), Liping Sun (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimised Electroporation for Loading of Extracellular Vesicles with Doxorubicin
by: Angus J. Lennaárd, et al.
Published: (2021) -
MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin
by: Justyna Totoń-Żurańska, et al.
Published: (2022) -
Doxorubicin Loading into Milk and Mesenchymal Stem Cells' Extracellular Vesicles as Drug Delivery Vehicles
by: Anindya Mukhopadhya, et al.
Published: (2023) -
A novel lonidamine derivative targeting mitochondria to eliminate cancer stem cells by blocking glutamine metabolism
by: Qiang Wang, et al.
Published: (2023) -
Dendritic Cell-Targeted pH-Responsive Extracellular Vesicles for Anticancer Vaccination
by: Hyuk Lee, et al.
Published: (2019)